Joseph Shatzel, M.D., M.C.R.

Joseph Shatzel, M.D., M.C.R., is an Associate Professor of Biomedical Engineering in the School of Medicine at Oregon Health & Science University. His research focuses on thrombosis, hemostasis, and anticoagulant pharmacology, with a particular emphasis on venous thrombosis and the development of novel factor XI inhibitors for atrial fibrillation. Recent work includes clinical trials on avatrombopag for chemotherapy-induced thrombocytopenia, single-dose intravenous iron for pregnancy-related anemia, and mechanistic studies of myosin-fibrin binding in trauma. He has also contributed to hematology referral guidelines for eosinophilia and emerging therapies for malignancy-associated anemia.